This trial will test if N-of-1 trials can help seniors with Heart Failure decide if they should stay on beta-blocker meds or not.
- Diastolic Heart Failure
- Heart Failure
- Heart Disease
2 Primary · 7 Secondary · Reporting Duration: Baseline, End of each period (approx. weeks 6, 12, 18, and 24), month 6 follow-up, month 9 follow-up, and month 12 follow-up
Awards & Highlights
2 Treatment Groups
Beta Blocker ABAB Sequence
1 of 2
Beta Blocker BABA Sequence
1 of 2
20 Total Participants · 2 Treatment Groups
Primary Treatment: Beta Blocker ABAB Sequence · No Placebo Group · Phase 4
Who is running the clinical trial?
Age 65+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
|Did not meet criteria||50.0%|
How many prior treatments have patients received?
What site did they apply to?
|Weill Cornell Medicine||100.0%|
Why did patients apply to this trial?
- "To help further understanding."
- "I would like to learn more about my condition, and possibly to see if there are any advances that may be able to help people like me in the future"
What questions have other patients asked about this trial?
- "How long do screening visits last?"
- "How long is the study, and what is the screening process, is there compensation for this study?"
Frequently Asked Questions
To what extent could the Beta Blocker ABAB Sequence be hazardous to human health?
"Beta Blocker ABAB Sequence has been approved, so our team rates its safety at a 3 on the scale." - Anonymous Online Contributor
Are there any available vacancies for participants in this trial?
"According to the documentation on clinicaltrials.gov, this particular medical trial is no longer taking in patients. It had initially been posted on December first 2022 and was last updated October 11th of the same year. Despite not recruiting any more participants for this study, there are still 990 other trials actively searching for volunteers at present time." - Anonymous Online Contributor